122 related articles for article (PubMed ID: 2511175)
1. Increased expression of ras genes in non-Hodgkin's lymphomas is not associated with oncogenic activation of those genes by point mutation.
Hamatani K; Nagata Y; Abe M; Abe K; Toki H; Ikeda S; Nakayama E; Shiku H
Jpn J Cancer Res; 1989 Aug; 80(8):706-10. PubMed ID: 2511175
[TBL] [Abstract][Full Text] [Related]
2. Histologic typing of non-Hodgkin's lymphomas by in situ hybridization with DNA probes of oncogenes.
Hamatani K; Yoshida K; Kondo H; Toki H; Okabe K; Motoi M; Ikeda S; Mori S; Shimaoka K; Akiyama M
Blood; 1989 Jul; 74(1):423-9. PubMed ID: 2526666
[TBL] [Abstract][Full Text] [Related]
3. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
[TBL] [Abstract][Full Text] [Related]
4. Point mutations of c-ras genes in human bladder cancer and kidney cancer.
Nagata Y; Abe M; Kobayashi K; Saiki S; Kotake T; Yoshikawa K; Ueda R; Nakayama E; Shiku H
Jpn J Cancer Res; 1990 Jan; 81(1):22-7. PubMed ID: 2108944
[TBL] [Abstract][Full Text] [Related]
5. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
6. Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure.
Marion MJ; Froment O; Trépo C
Mol Carcinog; 1991; 4(6):450-4. PubMed ID: 1793483
[TBL] [Abstract][Full Text] [Related]
7. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis.
Tsuda T; Mochizuki M; Wakasa H
J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
Soparker CN; O'Brien JM; Albert DM
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.
Tsuda H; Hirohashi S; Shimosato Y; Ino Y; Yoshida T; Terada M
Jpn J Cancer Res; 1989 Mar; 80(3):196-9. PubMed ID: 2542205
[TBL] [Abstract][Full Text] [Related]
10. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing.
Ahuja HG; Foti A; Bar-Eli M; Cline MJ
Blood; 1990 Apr; 75(8):1684-90. PubMed ID: 2183888
[TBL] [Abstract][Full Text] [Related]
11. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
Kwong YY; Husain Z; Biswas DK
Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
[TBL] [Abstract][Full Text] [Related]
12. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
[TBL] [Abstract][Full Text] [Related]
13. [Study of mutations in 5'-noncoding region of BCL-6 gene in B-cell non-Hodgkin's lymphomas].
Min DL; Zhou XY; Yang WT; Sun MH; Lu HF; Zhang TM; Zheng AH; Cao PZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):238-41. PubMed ID: 15256116
[TBL] [Abstract][Full Text] [Related]
14. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the Ki-ras oncogene in endometrial carcinoma.
Ignar-Trowbridge D; Risinger JI; Dent GA; Kohler M; Berchuck A; McLachlan JA; Boyd J
Am J Obstet Gynecol; 1992 Jul; 167(1):227-32. PubMed ID: 1442931
[TBL] [Abstract][Full Text] [Related]
16. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
Mitani S; Sugawara I; Shiku H; Mori S
Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
[TBL] [Abstract][Full Text] [Related]
18. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
19. Amino acid substitution at position 13 of the N-ras gene in a non-Hodgkin's lymphoma patient.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Haematol Blood Transfus; 1987; 31():172-4. PubMed ID: 3327770
[No Abstract] [Full Text] [Related]
20. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation.
Kihana T; Tsuda H; Hirota T; Shimosato Y; Sakamoto H; Terada M; Hirohashi S
Jpn J Cancer Res; 1991 Mar; 82(3):308-14. PubMed ID: 1902452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
